Evidence map›Paper›PMID 28122047›Full record

ArticlePloS one2017

Cryopreservation of GABAergic Neuronal Precursors for Cell-Based Therapy.

Daniel Rodríguez-Martínez, María Magdalena Martínez-Losa, Manuel Alvarez-Dolado

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. The clustered gamma protocadherin PcdhγC4 isoform regulates cortical interneuron programmed cell death in the mouse cortex.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniel Rodríguez-MartínezLaboratory of Cell-based Therapy for Neuropathologies, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), CSIC, Seville, Spain.
María Magdalena Martínez-LosaLaboratory of Cell-based Therapy for Neuropathologies, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), CSIC, Seville, Spain.
Manuel Alvarez-DoladoLaboratory of Cell-based Therapy for Neuropathologies, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), CSIC, Seville, Spain.ORCID http://orcid.org/0000-0002-0655-8289
Centro Andaluz de Biología Molecular y Medicina Regenerativa · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryopreservation protocols are essential for stem cells storage in order to apply them in the clinic. Here we describe a new standardized cryopreservation protocol for GABAergic neural precursors derived from the medial glanglionic eminence (MGE), a promising source of GABAergic neuronal progenitors for cell therapy against interneuron-related pathologies. We used 10% Me2SO as cryoprotectant and assessed the effects of cell culture amplification and cellular organization, as in toto explants, neurospheres, or individualized cells, on post-thaw cell viability and retrieval. We confirmed that in toto cryopreservation of MGE explants is an optimal preservation system to keep intact the interneuron precursor properties for cell transplantation, together with a high cell viability (>80%) and yield (>70%). Post-thaw proliferation and self-renewal of the cryopreserved precursors were tested in vitro. In addition, their migration capacity, acquisition of mature neuronal morphology, and potency to differentiate into multiple interneuron subtypes were also confirmed in vivo after transplantation. The results show that the cryopreserved precursor features remained intact and were similar to those immediately transplanted after their dissection from the MGE. We hope this protocol will facilitate the generation of biobanks to obtain a permanent and reliable source of GABAergic precursors for clinical application in cell-based therapies against interneuronopathies.

Indexed as

AnimalsCell- and Tissue-Based TherapyCell Culture TechniquesCell ShapeCell SurvivalCryopreservationCryoprotective AgentsGABAergic NeuronsInterneuronsMedian EminenceMiceNeural Stem CellsCryoprotective Agents

Identifiers

PMID28122047
PMCPMC5266290
OpenAlexW2582239852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.